Plantable Health Inc. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was USD 0.246603 million compared to USD 0.210798 million a year ago. Net loss was USD 0.721257 million compared to USD 0.516386 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.
For the nine months, sales was USD 0.979027 million compared to USD 0.867847 million a year ago. Net loss was USD 2.41 million compared to USD 3.69 million a year ago. Basic loss per share from continuing operations was USD 0.04 compared to USD 0.11 a year ago.